US21900C3088
US21900C3088
CorMedix Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 311.709.000 | 43.472.000 | 617.0% |
| Cost of Revenue | 35.961.000 | 3.190.000 | 1027.3% |
| Gross Profit | 275.748.000 | 40.282.000 | 584.5% |
| 125.607.000 | 62.638.000 | 100.5% | |
| Operating Income | 150.141.000 | -22.356.000 | 771.6% |
| Pretax Income | 150.016.000 | -19.325.000 | 876.3% |
| Net Income Common Stockholders | 162.067.000 | -17.930.000 | 1003.9% |
| -- | -- | -- | |
| -- | -- | -- |